Author

Miles P. Sparrow 1

1 University of Melbourne

ADALIMUMAB AND INFLIXIMAB CLEARANCE IN NEONATES (ERA STUDY)

Mette Julsgaard, Lisbet Ambrosius Christensen, Peter R. Gibson, Richard Blair Gearry, Jan Fallingborg, jens kjeldsen, Signe Wildt, Lise Svenningsen, William Connell, Christian Lodberg Hvas, Miles P. Sparrow, Alissa Walsh, Susan J. Connor, Graham Radford-Smith, Ian Lawrance, Jane Andrews, Katie Ellard, Ourania Rosella, Ann

ADJUNCTIVE ALLOPURINOL IN THIOPURINE NON-RESPONDERS OPTIMISES 6TGN AND IMPROVES CLINICAL OUTCOMES IN IBD: THE MULTICENTRE, PROSPECTIVE, DOUBLE BLIND, DOSE-RANGING AAA STUDY

Antony B. Friedman, Steven J. Brown, Peter A. Bampton, Murray Barclay, Alvin Chung, Finlay A. Macrae, John V. Reynolds, Peter R. Gibson, Stephen B Hanauer, Miles P. Sparrow

FAECAL CALPROTECTIN HELPS DETERMINE THE NEED FOR POST-OPERATIVE COLONOSCOPY IN CROHN’S DISEASE. PROSPECTIVE LONGITUDINAL ENDOSCOPIC VALIDATION. RESULTS FROM THE POCER STUDY.

Emily Wright, Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Steven Leach, Alexandra Gorelik, Lani Prideaux, Danny Liew, Ian Lawrence, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Pe

IMPACT OF CONCOMITANT IMMUNOMODULATOR TREATMENT ON EFFICACY AND SAFETY OF ANTI-TNF THERAPY IN CROHN’S DISEASE: A META-ANALYSIS OF PLACEBO CONTROLLED TRIALS WITH INDIVIDUAL PATIENT-LEVEL DATA

Jennifer Jones, Laurent Peyrin-Biroulet, L Baidoo, Shane Devlin, Gil Y. Melmed, D Tanyingoh, L Raffals, Peter Irving, Patricia Kozuch, Miles P. Sparrow, Fernando Velayos, Brian Bressler, A Cheifetz, Jean-Frederic Colombel, Corey A Siegel, Gilaad G. Kaplan

IS FECAL CALPROTECTIN THE BETTER TOOL TO MONITOR DISEASE ACTIVITY IN PREGNANT IBD PATIENTS?

Mette Julsgaard, Lisbet Ambrosius Christensen, Christian Lodberg Hvas, Jan Fallingborg, Lise Svenningsen, jens kjeldsen, Miles P. Sparrow, Signe Wildt, Sally J. Bell

Long-term mucosal healing, clinical response and clinical remission in patients with ulcerative colitis treated with the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody ontamalimab (SHP647): results from the open-label extension study TURANDOT II

Silvio Danese, William Sandborn, Walter Reinisch, Xavier Hebuterne, Maria Kłopocka, Dino Tarabar, Tomáš Vaňásek, Miloš Greguš, Paul A Hellstern, Joo Sung Kim, Miles P. Sparrow, Kenneth Gorelick, Martina Goetsch, Caleb Bliss, Charu Gupta, Fabio Cataldi, Severine Vermeire

LONG-TERM SAFETY OF THE ANTI-MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1) ANTIBODY SHP647 IN ULCERATIVE COLITIS: AN OPEN-LABEL EXTENSION STUDY (TURANDOT II)

Walter Reinisch, William Sandborn, Silvio Danese, Xavier Hebuterne, Bruce Salzberg, Maria Kłopocka, Dino Tarabar, Tomáš Vaňásek, Miloš Greguš, Paul A Hellstern, Joo Sung Kim, Miles P. Sparrow, Kenneth Gorelick, Martina Goetsch, Caleb Bliss, Fabio Cataldi, Severine Vermeire

OPTIMISING POST-OPERATIVE CROHN’S DISEASE MANAGEMENT: BEST DRUG THERAPY ALONE VERSUS ENDOSCOPIC MONITORING WITH TREATMENT STEP-UP. THE POCER STUDY

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

SMOKING IS THE KEY RISK FACTOR THAT DOUBLES THE RISK OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE DESPITE PREVENTIVE DRUG TREATMENT. RESULTS FROM THE POCER STUDY

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

STRATEGIC TIMING OF ANTI-TNF THERAPY IN POSTOPERATIVE CROHN’S DISEASE: COMPARISON OF ROUTINE USE IMMEDIATELY POSTOPERATIVELY WITH SELECTIVE USE AFTER DEMONSTRATED RECURRENCE AT 6 MONTH ENDOSCOPY. RESULTS FROM POCER

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

Item 1 - 10 / 17
1
2